Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Testoni

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|June 3, 1999
Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patientsG Visani, R M Lemoli, P Tosi, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|February 1, 1996
Fingerprinting of HLA class I genes for improved selection of unrelated bone marrow donorsG Martinelli, P Farabegoli, M Buzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Leukemia|March 1, 1996
Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemiaM C Miggiano, F Gherlinzoni, G Rosti, et al.
Leukemia|April 18, 2006
Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemiaR La Starza, A Aventin, C Matteucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myelomaG Martinelli, C Terragna, E Zamagni, et al.
Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
Leukemia|April 15, 2016
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosisM Martello, D Remondini, E Borsi, et al.
Blood Cancer Journal|January 27, 2022
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myelomaM Martello, A Poletti, E Borsi, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|June 3, 1999
Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patientsG Visani, R M Lemoli, P Tosi, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|February 1, 1996
Fingerprinting of HLA class I genes for improved selection of unrelated bone marrow donorsG Martinelli, P Farabegoli, M Buzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Leukemia|March 1, 1996
Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemiaM C Miggiano, F Gherlinzoni, G Rosti, et al.
Leukemia|April 18, 2006
Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemiaR La Starza, A Aventin, C Matteucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myelomaG Martinelli, C Terragna, E Zamagni, et al.
Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
Leukemia|April 15, 2016
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosisM Martello, D Remondini, E Borsi, et al.
Blood Cancer Journal|January 27, 2022
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myelomaM Martello, A Poletti, E Borsi, et al.
Pageof 12